Novartis Quote - NOTA | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
Germany
TG
Novartis AG (NOTA) Share Price

Novartis AG (NOTA)

94.40

0.00

(0.00%)

Closed January 01 3:00PM

Realtime Data

Professional-Grade Tools, for Individual Investors.

Current Price

94.40

Bid

94.40

Ask

94.40

Volume

0.00

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

Previous Close

94.40

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

-

Shares Outstanding

2,044,033,986

Dividend Yield

-

PE Ratio

13.22

Earnings Per Share (EPS)

7.27

Revenue

54.11B

Net Profit

14.85B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.novartis.com

Headquarters

Basel, Che

Founded

-

Novartis AG is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NOTA. The last closing price for Novartis was 94.40 €. Over the last year, Novartis shares have traded in a share price range of 0.00 € to 0.00 €.

Novartis currently has 2,044,033,986 shares outstanding. The market capitalization of Novartis is 192.96 € billion. Novartis has a price to earnings ratio (PE ratio) of 13.22.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

NOTA - Frequently Asked Questions (FAQ)

What is the current Novartis share price?

The current share price of Novartis is 94.40 €

How many Novartis shares are in issue?

Novartis has 2,044,033,986 shares in issue

What is the market cap of Novartis?

The market capitalisation of Novartis is EUR 192.96B

What is the 1 year trading range for Novartis share price?

Novartis has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Novartis?

The price to earnings ratio of Novartis is 13.22

What is the cash to sales ratio of Novartis?

The cash to sales ratio of Novartis is 3.63

What is the reporting currency for Novartis?

Novartis reports financial results in USD

What is the latest annual turnover for Novartis?

The latest annual turnover of Novartis is USD 54.11B

What is the latest annual profit for Novartis?

The latest annual profit of Novartis is USD 14.85B

What is the registered address of Novartis?

The registered address for Novartis is PO BOX, BASEL, 4002

What is the Novartis website address?

The website address for Novartis is www.novartis.com

Which industry sector does Novartis operate in?

Novartis operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
013CJDcom Inc	16.75 € (0.00%)	0
013AJD.com Inc	33.35 € (0.00%)	0
0110Thesis Gold Inc	0.373 € (0.00%)	0
00WAspermont Ltd	0.004 € (0.00%)	0
000Greenvolt Energias Renovaveis SA	0.00 € (0.00%)	0
013CJDcom Inc	16.75 € (0.00%)	0
013AJD.com Inc	33.35 € (0.00%)	0
0110Thesis Gold Inc	0.373 € (0.00%)	0
00WAspermont Ltd	0.004 € (0.00%)	0
000Greenvolt Energias Renovaveis SA	0.00 € (0.00%)	0
013CJDcom Inc	16.75 € (0.00%)	0
013AJD.com Inc	33.35 € (0.00%)	0
0110Thesis Gold Inc	0.373 € (0.00%)	0
00WAspermont Ltd	0.004 € (0.00%)	0
000Greenvolt Energias Renovaveis SA	0.00 € (0.00%)	0

DTGoody

DTGoody 4 minutes ago

Happy New Year! Hoping for a better year in 2025!

Value_Investor

Value_Investor 5 minutes ago

TNXP is Super Undervalued now! It is also at Hyper Oversold status! This Diamond-In-Rough is heading onto the Dollar Land again...

https://www.youtube.com/watch?v=PtwWU3pC-O4

MasterBlastr

MasterBlastr 6 minutes ago

Right - unlike Theory-slut, empty of any cogent thinking.

rbtree

rbtree 6 minutes ago

KEGS has been doing a fine job of burying itself for a long time...

StayHumble

StayHumble 9 minutes ago

💹Green's Great💹Set HIGH Sell Orders💹$9.9999💹wow

skitahoe

skitahoe 9 minutes ago

I know some people don't agree, but I don't believe the current manual production facility approve for use in the UK has sufficient capacity for the UK along, if that's true, until they have more capacity filing with other regulators isn't possible. The EDEN is the key unless someone's building lot

StayHumble

StayHumble 10 minutes ago

Xperts Are💹 JUMBO SHORT💹 $10 💹Markets Primed! wow!

Green Leaf Smoker

Green Leaf Smoker 11 minutes ago

QOUTE: Everything is going to pot....including MJNA as current value is a PATHETIC O.OOO3

StayHumble

StayHumble 12 minutes ago

💹34M BUYS💹+High Sell Orders💹$9.99991 wow https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3

froggmister

froggmister 12 minutes ago

I also do not recall that NWBO mentioned its intention to submit applications to
the EU. If that fact can be taken as evidence, we should also assume that any
potential treatments developed from the combo trials at UCLA, Roswell
Park, the DCVax-D trials and any future partnershi

StayHumble

StayHumble 13 minutes ago

wow💹.000001 BUYS💹MASSIVE SHORT Position 💹https://ih.advfn.com/stock-market/USOTC/omni-health-ce-OMHE/trades

qualityincolor

qualityincolor 13 minutes ago

Mexedia already had access once but then they changed their U.S. name of this branch to telvantis, which unfortunately lost them access to OTCIQ. They had to go through the process once again. Access will be granted again and very soon.

SantaZar

SantaZar 15 minutes ago

#DDAmanda Video - $BDMD - Gain: +483% Video Analysis - #1 Stock Screener / Scanner

Questions/Support: 760 702-2009 - Hans@DDAmanda.com

https://www.youtube.com/watch?v=1HmWGhZ8lrc

Z

SantaZar

SantaZar 15 minutes ago

#DDAmanda Video - $BDMD - Gain: +483% Video Analysis - #1 Stock Screener / Scanner

Questions/Support: 760 702-2009 - Hans@DDAmanda.com

https://www.youtube.com/watch?v=1HmWGhZ8lrc

Z

SantaZar

SantaZar 16 minutes ago

#DDAmanda Video - $BDMD - Gain: +483% Video Analysis - #1 Stock Screener / Scanner

Questions/Support: 760 702-2009 - Hans@DDAmanda.com

https://www.youtube.com/watch?v=1HmWGhZ8lrc

Z

SantaZar

SantaZar 16 minutes ago

Happy New Year Street!!!!!

Z

Rocky3

Rocky3 16 minutes ago

Appreciate the thoughts but other than cash your analysis effectively discounts all other assets such as retained royalties and Zelicapavir - just to name two.

The retained royalties are not enough to pay the company's expenses, so I would argue that they have no value for a going co

Tahoe2468

Tahoe2468 17 minutes ago

https://quantumzeitgeist.com/microcloud-hologram-advances-quantum-computing-with-spin-qubit-tech/

StayHumble

StayHumble 17 minutes ago

$AMC Silver investments Golden💹wow ShortFilmXplosion Coming💹

Hoghead7

Hoghead7 17 minutes ago

December 20 Hydrogen plan DOE offices! Rules out Friday
https://www.hydrogen.energy.gov/docs/hydrogenprogramlibraries/pdfs/hydrogen-program-plan-2024.pdf?sfvrsn=bfc739dd_1

Green Leaf Smoker

Green Leaf Smoker 17 minutes ago

Southernwind2021 indicates this play "PHIL" is DEAD / TOAST....game over!!!

3jack

3jack 18 minutes ago

Have you always been this pathetic?

blackhawks

blackhawks 18 minutes ago

Maybe, maybe not. If all they can do is lay down 'regret markers' for MAGAts with questions like 'if we do what you're on the record as wanting to do scientists/economists tell us the following will ensue.....what say you to that?'

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions